By Springer Healthcare IME Next-generation CAR-T cell therapy for high-risk LBCL and R/R DLBCL ...more
By Kamran Ahmad Integrating tumor microenvironment biology with clinical impact: Evolving understanding of therapeutic approaches for MF‑CTCL ...more
By Kamran Ahmad The AML expert series: Innovations in molecular testing, emerging therapies & targeted treatments ...more
By Kamran Ahmad Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond ...more
By Springer Healthcare IME Detecting and targeting NTRK fusions in NSCLC: a clinical pathway tool ...more
